Standout Papers

IL-6 and IL-8: An Overvie... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies
    2022 112 citations Aleksandra Vilotić, Mirjana Nacka-Aleksić et al. International Journal of Molecular Sciences profile →

Immediate Impact

49 hit
Sub-graph 1 of 24

Citing Papers

Antioxidant-Rich Functional Foods and Exercise: Unlocking Metabolic Health Through Nrf2 and Related Pathways
2025 Hit
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
2025 Hit
5 intermediate papers

Works of Dragana Dekanski being referenced

IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies
2022 Hit
Multiple antimelanoma potential of dry olive leaf extract
2010
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dragana Dekanski 235 169 167 164 160 44 910
Qin Yao 336 1.4× 152 0.9× 262 1.6× 96 0.6× 105 0.7× 44 1.0k
Narcyz Knap 149 0.6× 189 1.1× 290 1.7× 119 0.7× 102 0.6× 33 995
Mario Pulido‐Moran 198 0.8× 222 1.3× 318 1.9× 103 0.6× 69 0.4× 16 1.0k
Nassima Mokhtari-Soulimane 123 0.5× 81 0.5× 145 0.9× 74 0.5× 82 0.5× 34 946
Ahmed Y. Nassar 313 1.3× 112 0.7× 179 1.1× 48 0.3× 89 0.6× 31 786
Iahtisham Ul‐Haq 192 0.8× 78 0.5× 227 1.4× 205 1.3× 183 1.1× 27 1.0k
Loredana Stanca 133 0.6× 75 0.4× 253 1.5× 109 0.7× 147 0.9× 28 994
Ashfaq Ahmad 87 0.4× 91 0.5× 152 0.9× 143 0.9× 153 1.0× 59 870
Feral Öztürk 102 0.4× 45 0.3× 181 1.1× 100 0.6× 177 1.1× 40 935
Fereshteh Ghorat 149 0.6× 34 0.2× 173 1.0× 88 0.5× 147 0.9× 42 856

All Works

Loading papers...

Rankless by CCL
2026